Concepedia

Kajsa P. Kanebratt

KP

11

Publications

1.3K

Citations

10

H-Index

2007

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Karolinska Institutet

AstraZeneca (Brazil)

Karolinska University Hospital

Kajsa P. Kanebratt is an author at AstraZeneca (Sweden) specializing in liver physiology, hepatology, and metabolomics.

ORCID

Top concepts

Publications per year

2007–2022

11

Publications

11

Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies

Kajsa P. Kanebratt, Tommy B. Andersson · Drug Metabolism and Disposition · 2008 · 341 citations

Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model

Sophie Bauer, Charlotte Wennberg Huldt, Kajsa P. Kanebratt et al. · Scientific Reports · 2017 · 260 citations · Full text

HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans

Kajsa P. Kanebratt, Tommy B. Andersson · Drug Metabolism and Disposition · 2007 · 205 citations

4β‐Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half‐life of elimination after induction with rifampicin

Ulf Diczfalusy, Kajsa P. Kanebratt, Eva Bredberg et al. · British Journal of Clinical Pharmacology · 2008 · 120 citations · Full text

The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids

Sebastian Prill, Andrea Caddeo, Guido Baselli et al. · Scientific Reports · 2019 · 109 citations · Full text

, , +20

Rows per page

1–5 of 11